Summary of bi-shRNAfurin/GM-CSF Augmented Autologous Tumor Cell Immunotherapy (FANG™) in Advanced Cancer of the Liver

Publisher： Karger

E-ISSN： 1423-0232|87|1|21-29

ISSN： 0030-2414

Source： Oncology, Vol.87, Iss.1, 2014-06, pp. : 21-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Allogeneic Hematopoietic Cell Transplantation as Consolidation Immunotherapy of Cancer after Autologous Transplantation

By  

Acta Haematologica, Vol. 114, Iss. 4, 2005-11 ,pp. : 221-229

Karger

Access to resources Recommend Favorite

Dose Escalation of Carboplatin and Cyclophosphamide Supported by GM-CSF in the Treatment of Patients with Advanced Ovarian Cancer (FIGO III and IV) – a Phase I Study

By  

Oncology Research and Treatment, Vol. 22, Iss. 6, 2000-01 ,pp. : 502-506

Karger

Access to resources Recommend Favorite

GM-CSF in Sickle Cell Anemia Patients with Elevated Hb F

By  

Acta Haematologica, Vol. 102, Iss. 3, 2004-11 ,pp. : 140-143

Karger

Access to resources Recommend Favorite

Paclitaxel, Carboplatin, and G-CSF in Advanced Non-Small-Cell Lung Cancer: A Phase I/II Study

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1998-09 ,pp. : 310-314

Karger

Access to resources Recommend Favorite

Phase I Study of Cisplatin, Ifosfamide and Irinotecan with rhG-CSF Support in Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 56, Iss. 4, 1999-05 ,pp. : 301-307

Karger

Access to resources Recommend Favorite